Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,257,322
Closed -$110M 26
2021
Q4
$110M Buy
1,257,322
+369,506
+42% +$34.7M 2.06% 21
2021
Q3
$77.4M Buy
887,816
+83,119
+10% +$7.34M 1.81% 21
2021
Q2
$62.6M Buy
804,697
+88,764
+12% +$6.95M 1.68% 22
2021
Q1
$50.2M Buy
715,933
+119,560
+20% +$7.74M 1.75% 20
2020
Q4
$38.6M Buy
596,373
+93,126
+19% +$5.54M 1.68% 19
2020
Q3
$30M Buy
503,247
+128,073
+34% +$7.28M 1.72% 18
2020
Q2
$20.7M Buy
375,174
+64,470
+21% +$3.42M 1.81% 18
2020
Q1
$15M Buy
310,704
+55,427
+22% +$2.86M 1.99% 17
2019
Q4
$13.5M Buy
+255,277
New +$14.1M 1.83% 18

Other funds holding ORCL

Mirova US's ORCL Position: Q1 2022 in Review

Mirova US sold out of Oracle (ORCL) in Q1 2022, closing a stake of 1,257,322 shares — an estimated $110M sold.

Mirova US first reported a position in ORCL in Q4 2019 and held it in 9 quarters. The position peaked at $110M in Q4 2021. 2,266 funds tracked by Wall St. Rank hold ORCL as of Q1 2022.

  • Mirova US reported no remaining Oracle position as of Q1 2022 after selling out during the quarter.
  • Mirova US sold 1,257,322 Oracle shares in Q1 2022, an estimated $110M.
  • Mirova US first reported a position in Oracle in Q4 2019 and held it in 9 quarters.
  • Mirova US's Oracle position peaked at $110M in Q4 2021.
  • 2,266 funds tracked by Wall St. Rank held Oracle as of Q1 2022.

Based on Mirova US's 13F filing for Q1 2022, filed 6 May 2022.